The latest updates on prescription drugs and ways to save from the GoodRx medical team

Iclusig Sales Suspended

by Elizabeth Davis on November 4, 2013 at 1:47 pm

The FDA has requested that the manufacturer of Iclusig, Ariad Pharmaceuticals, suspend marketing and sales of the leukemia treatment due to potentially life-threatening side effects.

A recent investigation showed an increased frequency of blood clots and narrowing of blood vessels. About 24% of patients in one clinical trial and 48% of patients in another experienced serious, sometimes fatal or life-threatening adverse vascular events—this includes problems with blood flow, heart attack, and stroke.

If you’re taking Iclusig and it’s working for you, the FDA recommends that you discuss the risks vs the benefits with your health care provider. If the benefits do outweigh the risks, you’ll need to be treated under a special access program. You can find more information on the program here.

If you’re taking Iclusig and it hasn’t been helping, the FDA recommends that you speak to your provider about immediately discontinuing treatment and finding an alterntaive.

For more information and updates, see the FDA bulletin here.

Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.